BioPharmaQ&ARegulatory July 24, 2024 Quality Considerations for Using AI in Bio/Pharma In the second episode of the Ask the Expert video series, Susan J. Schniepp, distinguished… Ross Burns
ArticlesDownstreamDownstreamQ&A March 22, 2024 Top Tips for Successful Development of Antibody Chromatography Processes In this interview, Jakob Liderfelt, Product Manager at Cytiva, discusses main challenges faced during... admin-element
Q&A February 23, 2024 Discovering the unknown: How does in silico process development change PD scientists’ work? In silico process development for chromatography is a paradigm-shifting approach that redefines the... admin-element
ArticlesDownstream November 17, 2023 Top challenges in recombinant protein purification process development In this video, Emma Lind, Product Manager for Chromatography Resins at Cytiva answers questions from... admin-element
Q&AUpstream March 6, 2023 Optimizing your Cell Culture Process to Improve Productivity In this video, Mary Szorik and Alicia Elwood at Cytiva, discuss the rationale for cell… admin-element
DownstreamQ&A January 19, 2023 Chromatography for the Diversified Antibody Pipeline In this video, Eva Heldin, Section Manager of Antibody Application in R&D at Cytiva is… admin-element
BioPharmaQ&ARegulatory August 27, 2020 Mechanistic Modeling: Current Advantages and Future Opportunities in Biopharmaceutical Process Development Mechanistic modeling is considered a part of smart process development, which is a collection of... admin-element
DownstreamQ&A July 16, 2020 Next Generation Process Chromatography Chromatography is an essential part in the production of all biopharmaceuticals. Without it the... admin-element
BioPharmaBioPharmaBioPharmaBioPharmaDownstreamDownstreamDownstreamDownstreamRegulatoryRegulatoryRegulatoryRegulatoryUpstreamUpstreamUpstreamUpstream June 24, 2000 Placeholder admin-element